Wednesday, February 03, 2021 4:11:53 PM
Thank you for your email.
Halitron, Inc. continues to implement its roll up business model with the one of its objectives to be a current reporting OTC Markets trading Company. For the past year and half we have been focusing on portfolio operations with the goal to generate cash flows to support the pubco. We cannot comment on any specifics without reporting the information to all shareholders so please continue to check the OTC Markets portal and wwww.halitroninc.com for information.
Regards,
Investor Relations
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM